PharmaNordic ApS: Financial statements 2021
CVR: 36408464
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 738,342 and a net result of DKK 144,394 compared with DKK 574,368 the year before. That is an increase of 42.9% compared with the year before. Equity in the 2021 report amounted to DKK 489,897. The solvency ratio was 51.4%.
- Gross Profit
- DKK 738,342
- Profit/Loss
- DKK 144,394
- Equity
- DKK 489,897
- Total Assets
- DKK 952,481
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 738 t. | 144 t. | 490 t. | - |
| 2020 | - | 517 t. | 574 t. | 346 t. | - |
| 2019 | - | 289 t. | -88 t. | -229 t. | - |
| 2018 | - | 476 t. | 109 t. | -141 t. | - |
| 2017 | - | 242 t. | -51 t. | -251 t. | - |
Official annual report
Find more companies like PharmaNordic ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
PharmaNordic ApS has published its annual report for 2020. Gross profit came to DKK 516,628, and the net result was DKK 574,368.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.